Table 1 Characteristics of all patients for subgroup analysis
Variables | Discordant | Concordant | p |
|---|---|---|---|
n = 343 | n = 787 | ||
Age categories | 0.031 | ||
< 30 | 37.74% (n = 80) | 62.26% (n = 132) | |
30–45 | 28.36% (n = 226) | 71.64% (n = 571) | |
> 45 | 30.58% (n = 37) | 69.42% (n = 84) | |
Cytology results | < 0.001 | ||
NILM | 24.34% (n = 176) | 75.66% (n = 547) | |
ASC-US | 42.44% (n = 101) | 57.56% (n = 137) | |
LSIL | 39.58% (n = 57) | 60.42% (n = 87) | |
ASC-H | 66.67% (n = 4) | 33.33% (n = 2) | |
HSIL | 26.32% n = 5) | 73.68% (n = 14) | |
HPV subtypes | 0.001 | ||
Negative | 30.59% (n = 26) | 69.41% (n = 59) | |
Other HR-HPV positive | 37.91% (n = 127) | 62.09% (n = 208) | |
HPV16/18 | 26.76% (n = 190) | 73.24% (n = 520) | |
Transformation zone type | < 0.001 | ||
TZ 1 | 20.20% (n = 61) | 79.80% (n = 241) | |
TZ 2 | 32.56% (n = 42) | 67.44% (n = 87) | |
TZ 3 | 34.33% (n = 240) | 65.67% (n = 459) | |
Number of biopsies | 1.1603 ± 2.1180 | 1.4727 ± 1.5920 | 0.006 |